AQS.V - Aequus Pharmaceuticals Inc.

TSXV - TSXV Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 513.67M
Enterprise Value 314.24M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)9.88
Price/Book (mrq)17.00
Enterprise Value/Revenue 310.29
Enterprise Value/EBITDA 6-5.68

Trading Information

Stock Price History

Beta (3Y Monthly) 0.47
52-Week Change 3-5.56%
S&P500 52-Week Change 315.97%
52 Week High 30.2450
52 Week Low 30.1200
50-Day Moving Average 30.1414
200-Day Moving Average 30.1549

Share Statistics

Avg Vol (3 month) 367.68k
Avg Vol (10 day) 337.12k
Shares Outstanding 580.44M
Float 73.31M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Oct. 31, 2019) 427.27k
Short Ratio (Oct. 31, 2019) 40.35
Short % of Float (Oct. 31, 2019) 4N/A
Short % of Shares Outstanding (Oct. 31, 2019) 40.03%
Shares Short (prior month Sep. 30, 2019) 4101.88k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 31, 2018
Most Recent Quarter (mrq)Jun. 30, 2019

Profitability

Profit Margin -197.25%
Operating Margin (ttm)-193.43%

Management Effectiveness

Return on Assets (ttm)-66.83%
Return on Equity (ttm)-258.90%

Income Statement

Revenue (ttm)1.38M
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)5.10%
Gross Profit (ttm)1.41M
EBITDA -2.51M
Net Income Avi to Common (ttm)-2.73M
Diluted EPS (ttm)-0.0340
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.46M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)2.02M
Total Debt/Equity (mrq)248.35
Current Ratio (mrq)4.37
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-2.34M
Levered Free Cash Flow (ttm)-1.34M